Allocations
iCapital Network, a financial technology platform aiming to democratise alternative investments for high-net-worth individuals and their financial advisors, has completed its latest funding round which included participation by Morgan Stanley Investment Management.
Morgan Stanley’s investment, together with investments from UBS Financial Services, Inc. (NYSE: UBS) and lead investor BlackRock (NYSE: BLK), brings iCapital’s total funding to date to over USD50 million.
iCapital’s online platform offers investors and their advisors access to select alternative investments such as hedge funds and private equity funds. The platform is powered by iCapital’s end-to-end technology solution, which automates the unique subscription, administration and reporting
IK Investment Partners’ IK VIII Fund has entered into exclusive negotiations with Equistone to acquire a majority stake in Bretèche Industrie Group (Bretèche), a manufacturer of industrial equipment for the production of food, pharmaceutical, and cosmetic products.
The management team will reinvest alongside the Fund. Financial terms of the transaction are not disclosed and the completion of the transaction is subject to regulatory approvals.
Bretèche consists of six leading companies within their respective markets, designing, engineering manufacturing, and installing equipment for food, cosmetics and pharmaceutical production lines. The Group employs nearly 1,000 people and generated a turnover of approximately
Comparison Creator, a comparison software development company, has been bought out by its Managing Director and founder Steve Jones, as well as minority investors, with investment from financial information business Defaqto.
As part of its strategic growth plan, the Cwmbran based business has also agreed a partnership with Defaqto, who help consumers make better informed decisions. Defaqto will provide Ratings and data to Comparison Creator. Comparison Creator plans to triple its workforce by the end of 2017.
Launched in 2010, Comparison Creator provides a white-label breakdown comparison service for Gocompare.com, Moneysupermarket, Confused.com and Comparethemarket.com. It also provides home emergency
Private equity house Key Capital Partners (KCP) has backed the management team of YorkTest Laboratories Ltd in completing an MBO that sees CBPE Capital sell 100 per cent of its stake in the food intolerance testing business, which trades as YorkTest and Lorisian.
YorkTest is the UK market leader in food intolerance testing. The company offers comprehensive support to customers in identifying food intolerance and then guiding them through dietary changes with the aim of addressing ailments such as IBS, migraines and skin conditions. YorkTest applies a rigorous process at its York-based laboratory to determine specific food or drink reactions,
AnaCap Financial Partners (AnaCap), the specialist European financial services private equity firm has competed an offering by AnaCap Financial Europe SA SICAV-RAIF (AFE) of EUR325 million of senior secured floating rate notes due 2024.
The offering took place through the new Luxembourg Reserved Alternative Investment Fund, AFE, building on AnaCap’s long track record investing in portfolios of performing and non-performing debt across Europe.
Justin Sulger (pictured), Head of Credit Investments at AnaCap Financial Partners LLP says: “AnaCap has been able to complete this transaction thanks to its long-standing track record in the European debt purchase sector. Another valuable component
Promise Gluten Free, an innovative bakery which entered the gluten free market in 2012, has sold a majority stake to Mayfair Equity Partners (Mayfair).
Promise, based in Donegal, Ireland and founded in 2011, is a group of companies comprising Aran Ard Teoranta (trading as Gallagher’s Bakery) and Cuisine Royale Manufacturing Ltd. Promise has experienced rapid growth domestically in Ireland and internationally in markets including the UK, US and Australia under its retail brands: ‘Promise Gluten Free’ and ‘PureBred Gluten Free’. Promise mixes the best natural ingredients using a unique process to deliver baked goods with unparalleled nutritional value and award-winning
OMERS Private Equity has agreed to sell Civica to funds managed and/or advised by Partners Group, the global private markets investment manager, for a total consideration of GBP1,055 million, generating a 2.6x money multiple for OMERS.
Civica is a leading provider of business-critical software, digital solutions and technology-based outsourcing services to both public sector organisations and to commercial organisations in highly regulated sectors, in the UK and around the world. It has extensive capabilities and presence across local and central government, social housing, healthcare, education and public safety. The Company employs approximately 3,700 employees, around 75 per cent of
Ridge Road Capital Partners has completed the merger of legal software companies TrialWorks and Needles. Between them, the companies have a combined 55 years of operating history and over 2,500 law firm clients.
The combination of TrialWorks and Needles creates the leader in case management software for plaintiff-focused law firms, with a network of nearly 40,000 active users. The company will leverage the resources of both companies, as well as Ridge Road’s development partnerships, to accelerate product innovation and maintain best-in-class customer service and training. Ridge Road is committed to continuity for customers of both Needles and TrialWorks and to
Oak Hill Capital Partners (Oak Hill) has successfully closed Oak Hill Capital Partners IV (Fund IV), a USD2.65 billion private equity buyout fund.
The fund was significantly oversubscribed, surpassing its target of USD2.0 billion and its hard cap of USD2.5 billion.
Oak Hill will continue its 30-year history of successful private equity investing with Fund IV, leveraging its experienced team, longstanding theme-based investment philosophy, and systematic approach to value creation. Consistent with Oak Hill’s core philosophy of partnership through alignment of interests, the General Partner will remain the largest investor in Fund IV, with a USD300 million commitment.
Castlelake has completed the first and final closing of its fifth general purpose fund, Castlelake V at its hard cap of USD2.4 billion in capital commitments after four months of marketing.
The fund’s investor base consists of both existing and new Castlelake limited partners based in the US, Canada, Europe, Middle East and Asia.
“The formation of Castlelake V is a testament to the credibility of our investment strategy and the Castlelake team’s track record of identifying an opportunity set that spans sectors and cycles,” says Rory O’Neill, managing partner and CEO of Castlelake. “We are grateful to our
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
